Malaria vaccine gets EU nod

Malaria vaccine gets EU nod
Highlights

The world\'s first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease. The shot, called RTS,S or Mosquirix and developed by British drugmaker GlaxoSmithKline in partnership with the PATH MalariaVaccine Initiative,

London: The world's first malaria vaccine got a green light on Friday from European drugs regulators who recommended it should be licensed for use in babies in Africa at risk of the mosquito-borne disease. The shot, called RTS,S or Mosquirix and developed by British drugmaker GlaxoSmithKline in partnership with the PATH MalariaVaccine Initiative, would be the first licensed human vaccine against aparasitic disease and could help prevent millions of cases of malaria in countries that use it.


Recommendations for a drug licence made by the European Medicines Agency (EMA) are normally endorsed by the European Commission within a couple of months. Mosquirix, also part-funded by the Bill & Melinda Gates Foundation, will also now be assessed by the World Health Organisation.

Show Full Article
Download The Hans India Android App or iOS App for the Latest update on your phone.
More Stories


Top